The unifying theme of this application is the incidence of multiple chronic conditions (MCC) and its mechanisms and health outcomes. In the United States, about 62% of Medicare recipients ages 65 to 74 years have MCC (= 2 chronic conditions), and the frequency increases dramatically to 82% above age 85. Because adults with MCC are at increased risk of functional decline and are particularly vulnerable to poor care, MCC threatens both the public and financial health of the United States. MCC prevalence may be reduced by delaying the onset of single conditions and combinations of conditions through modification of risk factors or determinants of diseases. However, current preventive efforts have partly failed because they have focused on one disease at a time and too late in life. For this reason, there is a critical need to identify groups of individuals at risk earlier in life, an to develop interventions to prevent MCC and its adverse health outcomes. These priorities were outlined in the Multiple Chronic Conditions Strategic Framework of the US Department of Health and Human Services (DHHS) of 2010. The DHHS also developed a list of 20 conditions considered a public health priority for the nation. Although data are available about the prevalence of MCC in the United States and worldwide, the incidence of MCC and its epidemiologic mechanisms and health outcomes remain poorly understood. The Rochester Epidemiology Project (REP) is an ideal environment to study the incidence of MCC because it includes information for all ages from newborns to death, regardless of insurance status or health care setting (both inpatient and outpatient care), and encompasses the full spectrum of care, from primary to tertiary care. In this renewal application, we propose to study the mechanisms of development of incident MCC for specific physical and mental health conditions across all ages (Aim 1), and to identify short-term and long-term health outcomes of incident MCC dyads (Aim 2). This knowledge will inform earlier and more integrated interventions to prevent MCC and to improve its outcomes at the local community level and at the national level, as recommended by the DHHS and other federal agencies. Finally, we will develop an innovative approach to share REP data and our MCC findings to inform research and practice (Aim 3). Broad sharing of the comprehensive and longitudinal REP data both locally and to the wider scientific, clinical, and public health community will allow investigators and practitioners worldwide to rapidly explore patterns of diseases, procedures, drug prescriptions, MCC, and their associations at no cost. In summary, the studies proposed here are novel, can be efficiently conducted using the REP, and are urgently needed.

Public Health Relevance

We propose to study the mechanisms and the health outcomes of newly developed multiple chronic conditions using the records-linkage system of the unique Rochester Epidemiology Project, which has captured comprehensive information about the medical care delivered to local residents since the 1960s. Our ultimate goal is to provide evidence to guide the prevention of multiple chronic conditions, and to improve health outcomes for those already affected. The studies proposed here are novel, can be efficiently conducted using the Rochester Epidemiology Project, and are urgently needed.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG034676-54
Application #
9697243
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Dutta, Chhanda
Project Start
2010-07-01
Project End
2020-09-30
Budget Start
2019-06-01
Budget End
2020-09-30
Support Year
54
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Laughlin-Tommaso, Shannon K; Khan, Zaraq; Weaver, Amy L et al. (2018) Cardiovascular and metabolic morbidity after hysterectomy with ovarian conservation: a cohort study. Menopause 25:483-492
Rocca, Walter A; Grossardt, Brandon R; Brue, Scott M et al. (2018) Data Resource Profile: Expansion of the Rochester Epidemiology Project medical records-linkage system (E-REP). Int J Epidemiol 47:368-368j
Hommeida, S; Grothe, R M; Hafed, Y et al. (2018) Assessing the incidence trend and characteristics of eosinophilic esophagitis in children in Olmsted County, Minnesota. Dis Esophagus 31:
Petterson, Tanya M; Smith, Carin Y; Emerson, Jane A et al. (2018) Venous Thromboembolism (VTE) Incidence and VTE-Associated Survival among Olmsted County Residents of Local Nursing Homes. Thromb Haemost 118:1316-1328
Botha, Hugo; Mantyh, William G; Murray, Melissa E et al. (2018) FDG-PET in tau-negative amnestic dementia resembles that of autopsy-proven hippocampal sclerosis. Brain 141:1201-1217
Miller, Virginia M; Kling, Juliana M; Files, Julia A et al. (2018) What's in a name: are menopausal ""hot flashes"" a symptom of menopause or a manifestation of neurovascular dysregulation? Menopause 25:700-703
Aniwan, Satimai; Pardi, Darrell S; Tremaine, William J et al. (2018) Increased Risk of Acute Myocardial Infarction and Heart Failure in Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol 16:1607-1615.e1
Dziadzko, Volha; Clavel, Marie-Annick; Dziadzko, Mikhail et al. (2018) Outcome and undertreatment of mitral regurgitation: a community cohort study. Lancet 391:960-969
Shah, Saumya M; Martinez-Thompson, Jennifer M; Diehl, Nancy N et al. (2018) Adult-onset nonparalytic, small-angle hypertropia. J AAPOS 22:438-440
Jack Jr, Clifford R; Wiste, Heather J; Schwarz, Christopher G et al. (2018) Longitudinal tau PET in ageing and Alzheimer's disease. Brain 141:1517-1528

Showing the most recent 10 out of 881 publications